Walgreens: The Settlement Over Prescriptions Never Picked Up

Walgreens agreed to pay $106.8 million to resolve allegations that it billed government health care programs for prescriptions never picked up. For someone who works with prescription claims, the case reaches a familiar point in the transaction: the prescription has been processed, but the patient has not walked away with the medication. The allegation is simple: taxpayers paid for medicine nobody handed over.

The Department of Justice announced the settlement on September 13, 2024. It alleged that Walgreens submitted false claims to Medicare, Medicaid and other federal healthcare programs between 2009 and 2020. The government said the company received tens of millions of dollars for prescriptions it never provided. This pharmaceutical fraud case concerned the pharmacy’s own billing and whether the medicine reached the patient.

What the Paid Claim Was Supposed to Match

Walgreens allegedly processed the prescription and obtained government payment even though the beneficiary never collected the medication.

The movement of medicine and the movement of money can separate at the pharmacy counter. In the Walgreens allegations, the program paid even though the final handoff to the patient never happened.

A reversal is the billing side catching up with the failed pickup. We examine the paid claim, the pickup record and any reversal or refund with the insider who understands them. A successful claim submission tells only part of that story.

That distinction is also why the system changes matter. The Justice Department said Walgreens enhanced its electronic pharmacy management system to prevent the problem from recurring. The company also reported some of the conduct itself. The government gave it credit for that disclosure, its cooperation and its corrective work.

The U.S. Attorney for the Eastern District of Texas made clear why the billing systems mattered:

The Qui Tam Cases Behind the Settlement

Three separately filed qui tam cases brought the Walgreens billing allegations before courts in New Mexico, Texas and Florida. The settlement resolved all three. These are whistleblower cases brought on the government’s behalf under the False Claims Act, with the person bringing the case able to share in a recovery.

The Justice Department identified a former Walgreens pharmacy manager behind the Texas case. That case concerned billing Medicare, Medicaid and other federal health care programs. A former district pharmacy supervisor brought the New Mexico case concerning Medicare Part B billing.

Those roles put the case inside pharmacy operations. Someone familiar with the work can explain what a processed prescription means, what a pickup means and where the records should meet.

Previous Refunds Counted Toward the Settlement

Walgreens had already refunded $66,314,790 on the claims being settled, and the government credited that money toward the settlement. The announced amount therefore included money already returned.

How Much Money Do Pharmaceutical Whistleblowers Get for Exposing Fraud?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In the Walgreens resolution, the Justice Department announced separate rewards for the former pharmacy manager and the former district pharmacy supervisor.

The former pharmacy manager was to receive about $14.9 million. The former district pharmacy supervisor was to receive $1.62 million.

The case puts a concrete value on knowledge of pharmacy billing. The people behind those rewards had worked inside the business whose claims the government was paying.

DaVita Rx and the Missing Reversal

DaVita Rx faced a separate case involving allegations that drugs were billed but never shipped or were returned. The case also covered delivery and refill documentation and financial inducements to beneficiaries. Its December 14, 2017 resolution totaled $63.7 million, including previous repayments.

The whistleblowers’ amended complaint described how an insurance test allegedly became an actual paid claim for medication that never shipped. It also described medicine left uncollected without the government getting its money back:

The passage makes the missing reversal tangible. A prescription can remain in the payment records even when the medicine has not reached the patient. The DaVita allegations concerned its own shipping and dispensing practices, while the Walgreens allegations centered on prescriptions never picked up. Both make the same comparison worth examining: what the program paid for against what the patient actually received.

Another pharmacy case concerned an earlier step. In the Walmart and Sam’s Club automatic-refill settlement, the government alleged that automatic refills violated Minnesota Medicaid’s requirement for a beneficiary request for each refill. The patient’s request, the pickup and the payment each tell a different part of a pharmacy billing story.

What Pharmacy Insiders Can See in the Records

The useful evidence connects a government payment to what happened to the prescription. Pharmaceutical whistleblowers who know the dispensing process can explain why a paid claim, a shipment or pickup entry and a reversal do or do not describe the same completed transaction.

A 2020 University of Portsmouth doctoral study asked working U.S. pharmacists about professional decisions. Of the practices tested, leaving an uncollected prescription unreversed drew the strongest disagreement. For the pharmacists in that survey, an uncollected prescription still called for a billing correction.

For the Walgreens allegations, that puts the focus on the gap between processing and collection. We look at what the claim says was paid, what the dispensing records say happened and whether the money went back when the prescription went uncollected. We also examine who understood the mismatch and how the company responded.

An insider’s contribution is the explanation connecting those entries. If you worked with uncollected prescriptions, billing corrections or pharmacy systems, you may understand why a claim remained paid after the patient failed to collect the prescription.

You Know Why the Claim Stayed Paid

If you know why claims stayed paid after prescriptions went uncollected, speak to one of our whistleblower experts about those transactions. We work with you to build your strongest pharmacy whistleblower case, bring in pharmaceutical fraud whistleblower lawyers who understand pharmacy billing, and stay beside you throughout the case.